|
1
|
Boersma E, Mercado N, Poldermans D,
Gardien M, Vos J and Simoons ML: Acute myocardial infarction.
Lancet. 361:847–858. 2003.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rumana N, Kita Y, Turin TC, Murakami Y,
Sugihara H, Morita Y, Tomioka N, Okayama A, Nakamura Y, Abbott RD
and Ueshima H: Trend of increase in the incidence of acute
myocardial infarction in a Japanese population: Takashima AMI
registry, 1990-2001. Am J Epidemiol. 167:1358–1364. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ferrières J, Cambou JP, Ruidavets JB and
Pous J: Trends in acute myocardial infarction prognosis and
treatment in southwestern France between 1985 and 1990 (the MONICA
Project-Toulouse). Am J Cardiol. 75:1202–1205. 1995.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Anderson JL and Morrow DA: Acute
myocardial infarction. N Engl J Med. 376:2053–2064. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Açıkgöz Ş, Edebali N, Barut F, Can M,
Tekin İÖ, Büyükuysal Ç and Açıkgöz B: Ischemia modified albumin
increase indicating cardiac damage after experimental subarachnoid
hemorrhage. BMC Neurosci. 15(33)2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tripodi A: D-dimer testing in laboratory
practice. Clin Chem. 57:1256–1262. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Andreescu AC, Cushman M and Rosendaal FR:
D-dimer as a risk factor for deep vein thrombosis: The Leiden
thrombophilia study. Thromb Haemost. 87:47–51. 2002.PubMed/NCBI
|
|
8
|
Lloyd CM, Minto AW, Dorf ME, Proudfoot A,
Wells TN, Salant DJ and Gutierrez-Ramos JC: RANTES and monocyte
chemoattractant protein-1 (MCP-1) play an important role in the
inflammatory phase of crescentic nephritis, but only MCP-1 is
involved in crescent formation and interstitial fibrosis. J Exp
Med. 185:1371–1380. 1997.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ryan TJ, Antman EM, Brooks NH, Califf RM,
Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE
III, et al: 1999 update: ACC/AHA guidelines for the management of
patients with acute myocardial infarction. A report of the American
college of cardiology/American heart association task force on
practice guidelines (committee on management of acute myocardial
infarction). J Am Coll Cardiol. 34:890–911. 1999.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gong X, Zhou R and Li Q: Effects of
captopril and valsartan on ventricular remodeling and inflammatory
cytokines after interventional therapy for AMI. Exp Ther Med.
16:3579–3583. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rubinfeld GD, Smilowitz NR, Berger JS and
Newman JD: Association of thrombocytopenia, revascularization, and
in-hospital outcomes in patients with acute myocardial infarction.
Am J Med. 132:942–948.e5. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rasmussen MB, Stengaard C, Sørensen JT,
Riddervold IS, Hansen TM, Giebner M, Rasmussen CH, Bøtker HE and
Terkelsen CJ: Predictive value of routine point-of-care cardiac
troponin T measurement for prehospital diagnosis and
risk-stratification in patients with suspected acute myocardial
infarction. Eur Heart J Acute Cardiovasc Care. 8:299–308.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gruber HE, Hoelscher GL, Ingram JA, Bethea
S, Cox M and Hanley EN Jr: Proinflammatory cytokines modulate the
chemokine CCL2 (MCP-1) in human annulus cells in vitro: CCL2
expression and production. Exp Mol Pathol. 98:102–105.
2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Niu J and Kolattukudy PE: Role of MCP-1 in
cardiovascular disease: Molecular mechanisms and clinical
implications. Clin Sci (Lond). 117:95–109. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Buitrago L, Zafar H, Zhang Y, Li J, Walz T
and Coller BS: Dominant role of αIIbβ3 in platelet interactions
with cross-linked fibrin fragment D-dimer. Blood Adv. 4:2939–2949.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Simes J, Robledo KP, White HD, Espinoza D,
Stewart RA, Sullivan DR, Zeller T, Hague W, Nestel PJ, Glasziou PP,
et al: D-dimer predicts long-term cause-specific mortality,
cardiovascular events, and cancer in patients with stable coronary
heart disease: LIPID Study: LIPID Study. Circulation. 138:712–723.
2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shaw E, Massaro J, Levy D, O'Donnell CJ,
D'Agostino R and Tofler G: D-dimer and the risk of cardiovascular
disease: The Framingham heart study. Heart Lung Circ. 20 (Suppl
2)(S30)2011.
|
|
18
|
Kim KS, Shin SD, Song KJ, Suh GJ and Shin
S: Prognosis of patients with out-of-hospital cardiac arrest and
early biochemical markers: Ischemia modified albumin,
procalictonin, and S-100 protein. J Korean Soc Emerg Med.
17:281–290. 2006.
|
|
19
|
Sokhanvar S, Mellati AO, Mousavinasab SN,
Taran L, Vahdani B and Golmmohamadi Z: Ischemia-modified albumin
(IMA) in differential diagnosis of transient myocardial ischemia
from non ischemic chest pain. Bratisl Lek Listy. 113:612–615.
2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhong Y, Wang N and Xu H: The value of
ischaemia modified albumin in the diagnosis on coronary
atherosclerotic heart disease. Heart. 97 (Suppl
3)(A134)2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang CL, Jiang YM, Gao X and Wang X:
Clinical value of h-FABP, hs-CRP, cTnT examination to diagnose
acute myocardial infarction. J Dalian Med Univ. 30:170–172.
2008.
|
|
22
|
Devaki RN, Suma MN, Gowdappa HB, et al:
HS-CRP levels in myocardial infarction patients in relation to
cardiac markers, 2011.
|
|
23
|
Keller T, Zeller T, Peetz D, Tzikas S,
Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Fröhlich M, et al:
Sensitive troponin I assay in early diagnosis of acute myocardial
infarction. N Engl J Med. 361:868–877. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chan D and Ng LL: Biomarkers in acute
myocardial infarction. BMC Med. 8(34)2010.PubMed/NCBI View Article : Google Scholar
|
